Clinical trial

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure…

NCT00361634 · Amgen, Industry · Completed

Key facts

NCT number NCT00361634
Title Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis
Official title DCE-MRI of the Wrist to Measure Short-Term Responses in Rheumatoid Arthritis Subjects Treated With Etanercept
Lead sponsor Amgen, Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Rheumatoid Arthritis
Intervention type Drug
Interventions Etanercept
Enrollment 14
Start date Sep 1, 2006
Primary completion Aug 1, 2009
Completion Mar 1, 2010
First posted Aug 8, 2006
Last update posted Sep 17, 2013
Countries United Kingdom, United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies